{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:50:22Z","timestamp":1761515422122,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.4158\/ep.12.5.514","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:42:20Z","timestamp":1365198140000},"page":"514-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of Protease Inhibitors on Glucose Tolerance, Lipid Metabolism, and Body Composition in Children and Adolescents Infected With Human Immunodeficiency Virus"],"prefix":"10.1016","volume":"12","author":[{"given":"Berrin","family":"Ergun-Longmire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Lin-Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsis","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Sison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Stavola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G.","family":"Vogiatzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.12.5.514_bb0005","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","article-title":"(Pediatric AIDS Clinical Trials Group Protocol 219 Team). Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1","volume":"345","author":"Gortmaker","year":"2001","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.12.5.514_bb0010","first-page":"518","article-title":"Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome","volume":"17","author":"Sellmeyer","year":"1996","journal-title":"Endocr Rev."},{"key":"10.4158\/EP.12.5.514_bb0015","first-page":"107","article-title":"Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)","volume":"21","author":"Dong","year":"1999","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.4158\/EP.12.5.514_bb0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00042560-199903010-00003","article-title":"Studies of body composition and fat distribution in HIV-infected and control subjects","volume":"20","author":"Kotler","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol."},{"key":"10.4158\/EP.12.5.514_bb0025","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS."},{"key":"10.4158\/EP.12.5.514_bb0030","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS."},{"key":"10.4158\/EP.12.5.514_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.4158\/EP.12.5.514_bb0040","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS."},{"key":"10.4158\/EP.12.5.514_bb0045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00002030-199904160-00020","article-title":"Lipodystrophy in patients naive to HIV protease inhibitors","volume":"13","author":"Madge","year":"1999","journal-title":"AIDS."},{"key":"10.4158\/EP.12.5.514_bb0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med."},{"key":"10.4158\/EP.12.5.514_bb0055","doi-asserted-by":"crossref","DOI":"10.1542\/peds.110.5.e56","article-title":"Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy","volume":"110","author":"Lainka","year":"2002","journal-title":"Pediatrics."},{"key":"10.4158\/EP.12.5.514_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00006454-200205000-00011","article-title":"Lipodystrophy syndrome in human immunodeficiency virus-infected children","volume":"21","author":"Amaya","year":"2002","journal-title":"Pediatr Infect Dis J."},{"key":"10.4158\/EP.12.5.514_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s150100070021","article-title":"(Pediatric AIDS Group of Switzerland). Long-term responses to treatment including ritonavir or nelfinavir in HIV-1-infected children","volume":"28","author":"Nadal","year":"2000","journal-title":"Infection."},{"key":"10.4158\/EP.12.5.514_bb0070","series-title":"Presented at: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Abnormal body fat accumulations in HIV-infected children on antiretroviral therapy","author":"Regan","year":"1998"},{"key":"10.4158\/EP.12.5.514_bb0075","first-page":"1","article-title":"Revised classification system for human immunodeficiency virus infection in children less than 13 years of age","volume":"43","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.4158\/EP.12.5.514_bb0080","unstructured":"National Institutes of Health. National Cholesterol Education Program, ATP III Guidelines At-A-Glance Quick Desk Reference. Bethesda, MD: National Heart, Lung, and Blood Institute, May 2001. NIH Publication no. 01-3305. Available at: http:\/\/www.nhlbi.nih.gov\/guide-lines\/cholesterol\/atglance.pdf. Accessed for verification March 1, 2006."},{"key":"10.4158\/EP.12.5.514_bb0085","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","volume":"20","author":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"1997","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.12.5.514_bb0090","series-title":"Switzerland: World Health Organization","article-title":"Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva","author":"World Health Organization","year":"1999"},{"key":"10.4158\/EP.12.5.514_bb0095","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"(Expert Committee on the Diagnosis and Classification of Diabetes Mellitus). Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.12.5.514_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-8227(90)90040-Z","article-title":"Insulin release and peripheral sensitivity at the oral glucose tolerance test","volume":"10","author":"Cederholm","year":"1990","journal-title":"Diabetes Res Clin Pract."},{"key":"10.4158\/EP.12.5.514_bb0105","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative Insulin Sensitivity Check Index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.5.514_bb0110","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1053\/meta.2002.34029","article-title":"Comparison between beta-cell function and insulin resistance indexes in prepubertal and pubertal obese children","volume":"51","author":"Guzzaloni","year":"2002","journal-title":"Metabolism."},{"key":"10.4158\/EP.12.5.514_bb0115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2337\/diacare.27.2.314","article-title":"Indexes of insulin resistance and secretion in obese children and adolescents: a validation study","volume":"27","author":"Conwell","year":"2004","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.12.5.514_bb0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-543X.2004.00050.x","article-title":"Pubertal changes in HOMA and QUICKI: relationship to hepatic and peripheral insulin sensitivity","volume":"5","author":"Hoffman","year":"2004","journal-title":"Pediatr Diabetes."},{"key":"10.4158\/EP.12.5.514_bb0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.inf.0000068209.03069.2e","article-title":"Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children treated with protease inhibitors","volume":"22","author":"Bockhorst","year":"2003","journal-title":"Pediatr Infect Dis J."},{"key":"10.4158\/EP.12.5.514_bb0130","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet."},{"key":"10.4158\/EP.12.5.514_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.ijo.0802176","article-title":"Severe insulin resistance contrasting with mild anthropometric changes in the adipose tissue of HIV-infected children with lipohypertrophy","volume":"27","author":"Beregszaszi","year":"2003","journal-title":"Int J Obes Relat Metab Disord."},{"key":"10.4158\/EP.12.5.514_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM198607243150402","article-title":"Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes","volume":"315","author":"Amiel","year":"1986","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.12.5.514_bb0145","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1542\/peds.114.2.e235","article-title":"Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens","volume":"114","author":"Taylor","year":"2004","journal-title":"Pediatrics."},{"key":"10.4158\/EP.12.5.514_bb0150","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00002030-200306130-00006","article-title":"Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children","volume":"17","author":"Bitnun","year":"2003","journal-title":"AIDS."},{"key":"10.4158\/EP.12.5.514_bb0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00042560-200105010-00005","article-title":"Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+-lymphocyte count and CD4+-lymphocyte percentage at baseline and use of protease inhibitors and stavudine","volume":"27","author":"Arpadi","year":"2001","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.4158\/EP.12.5.514_bb0160","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","article-title":"Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children","volume":"14","author":"Jaquet","year":"2000","journal-title":"AIDS."},{"key":"10.4158\/EP.12.5.514_bb0165","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1089\/088922201316912727","article-title":"Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors","volume":"17","author":"Melvin","year":"2001","journal-title":"AIDS Res Hum Retroviruses."},{"key":"10.4158\/EP.12.5.514_bb0170","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe","volume":"18","author":"European Paediatric Lipodystrophy Group","year":"2004","journal-title":"AIDS."},{"key":"10.4158\/EP.12.5.514_bb0175","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","article-title":"Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children","volume":"32","author":"Vigano","year":"2003","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.4158\/EP.12.5.514_bb0180","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1345\/aph.1A444","article-title":"Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors","volume":"37","author":"Temple","year":"2003","journal-title":"Ann Pharmacother."},{"key":"10.4158\/EP.12.5.514_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(03)00246-6","article-title":"HIV-related lipodystrophy and related factors","volume":"174","author":"Tershakovec","year":"2004","journal-title":"Atherosclerosis."},{"key":"10.4158\/EP.12.5.514_bb0190","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS."},{"key":"10.4158\/EP.12.5.514_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00042560-200201010-00003","article-title":"Body habitus changes and metabolic alterations in protease inhibitornaive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors","volume":"29","author":"Galli","year":"2002","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"5 Pt 1","key":"10.4158\/EP.12.5.514_bb0200","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1067\/mjd.2000.104791","article-title":"Fat redistribution in HIV disease","volume":"42","author":"Rodwell","year":"2000","journal-title":"J Am Acad Dermatol."},{"key":"10.4158\/EP.12.5.514_bb0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00042560-200004010-00012","article-title":"Lipodystrophy: results of a data evaluation of patients receiving nelfinavir-containing combination therapy [letter]","volume":"23","author":"Lewis","year":"2000","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.4158\/EP.12.5.514_bb0210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00126334-200011010-00014","article-title":"Lipoatrophy, fat accumulation, and mixed syndrome in protease inhibitor-naive HIV-infected patients [letter]","volume":"25","author":"Polo","year":"2000","journal-title":"Acquir Immune Defic Syndr."},{"key":"10.4158\/EP.12.5.514_bb0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00126334-200010010-00007","article-title":"Fat redistribution in indinavir-treated patients with HIV infection: a review of postmarketing cases","volume":"25","author":"Benson","year":"2000","journal-title":"J Acquir Immune Defic Syndr."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/2TXM7M6PC0LXW4GG.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:12Z","timestamp":1761515232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20422815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1530891X20422815"],"URL":"https:\/\/doi.org\/10.4158\/ep.12.5.514","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Protease Inhibitors on Glucose Tolerance, Lipid Metabolism, and Body Composition in Children and Adolescents Infected With Human Immunodeficiency Virus","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.12.5.514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}